论文部分内容阅读
目的:研究分析血塞通注射液治疗腔隙性脑梗塞的临床疗效。方法:选取本院2015年7月~2016年9月收治的腔隙性脑梗塞患者105例,依据患者治疗用药差异性分组观察,均实施抗凝、控血压,调整颅内压等基础急救处理,其中观察组53例,采取血塞通注射液用药,对照组52例,采用脉络宁注射液用药,对比两组疗效。结果:观察组治疗总有效率94.34%(50/53),对照组治疗总有效率78.85%(41/52),观察组临床疗效优于对照组,差异有统计学意义(X2=5.45,P<0.05));观察组患者用药安全性亦优于对照组,差异有统计学意义(X2=4.46,P<0.05)。结论:腔隙性脑梗塞采用血塞通注射液治疗效果确切,无明显毒副反应,安全性较高。
Objective: To study the clinical efficacy of Xuesaitong injection in treating lacunar infarction. Methods: A total of 105 lacunar patients with cerebral infarction admitted from July 2015 to September 2016 in our hospital were enrolled in this study. According to the different treatment groups, patients were given basic first aid treatment such as anticoagulation, blood pressure control and intracranial pressure adjustment , Of which 53 cases of observation group, taking Xuesaitong injection, the control group of 52 cases, the Mailuoning injection medication, the two groups were compared. Results: The total effective rate was 94.34% (50/53) in the observation group and 78.85% (41/52) in the control group. The clinical efficacy in the observation group was better than that in the control group (X2 = 5.45, P <0.05)). The safety of medication in the observation group was also better than that of the control group, with significant difference (X2 = 4.46, P <0.05). Conclusion: The lacunar infarction with Xuesaitong injection has the exact effect, no obvious side effects and high safety.